December 11, 2019

Global Sciences Signs Agreement to Expand Aethics Product Distribution

CBD Global Sciences, Inc. today expanded its Aethics brand through a distribution agreement with a leading specialty beverages and healthy lifestyle products company. This agreement expands access to traditional retail, e-commerce, and other supply channels nationally. This opportunity will increase distribution of Aethics products with some of the world’s largest […]
December 5, 2019

Global Sciences Reports Q3 2019 Results with Revenue of $1.79 million up over 1,000% from Q3 2018 Revenue of $144,000

CBD Global Sciences, Inc.  today announced the release of financial and operational results for the third quarter ended September 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in U.S. dollars. Financial Highlights For the nine months ended September 30, […]
November 25, 2019

Global Sciences Achieves Listing on The Frankfurt Stock Exchange

CBD Global Sciences, Inc. today announced that its common shares have been listed on the Frankfurt Stock Exchange under the symbol “GS3.” The Company’s common shares continue to be listed on the Canadian Securities Exchange under the symbol “CBDN.” Brad Wyatt, CEO of the Company, commented, “we are excited to […]
November 13, 2019

Global Sciences Announces Aethics Product Line Now Carried by Minute Suites in US Airports

 CBD Global Sciences, Inc.  is pleased to announce that Minute Suites, a wellness-based solution for travelers located in airports throughout the United states, has commenced selling Aethics product line, which include CBD Daily Active lotion, Muscle Rescue lotion, among others in locations nationwide. This partnership builds upon CBD Global Sciences’ […]